| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/07/1999 | EP0906268A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 04/07/1999 | EP0906262A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 04/07/1999 | EP0906119A1 Method of treatment |
| 04/07/1999 | EP0906106A1 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
| 04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
| 04/07/1999 | EP0906099A1 A method of treating cancer |
| 04/07/1999 | EP0906095A1 7-o-methoxymethyl paclitaxel |
| 04/07/1999 | EP0906090A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 04/07/1999 | EP0854716A4 Androgenic directed compositions |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0705264B1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0481994B1 Metallo-organic cobalt compounds and uses thereof |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213378A Antitumor substance extracted from Grifola |
| 04/07/1999 | CN1213316A Polymeric delivery of radionuclides and radiopharmaceuticals |
| 04/07/1999 | CN1213315A Compositions including calcium influx retardant for inhibiting cell growth |
| 04/07/1999 | CN1213313A Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 04/07/1999 | CN1213310A Product of heat treatment of uronic acid, food, drink or drug including the product |
| 04/07/1999 | CN1213302A Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 04/07/1999 | CN1213300A Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | CN1212967A Parathormone related protein human source antibody and its preparation method |
| 04/07/1999 | CN1212874A 'Futekang' traditional Chinese medicine emulsion and preparation method thereof |
| 04/06/1999 | US5892112 Acylation of amino acids with anhydrides or carboxy groups, amidation with amine and conversion of acid or ester to hydroxamic acid and hydrolysis |
| 04/06/1999 | US5892063 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 04/06/1999 | US5892036 Process for the preparation of 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines |
| 04/06/1999 | US5892024 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891992 Processes for affecting in various ways the metabolism of animals using such modified peptides and vaccines |
| 04/06/1999 | US5891905 Methods of treatment using procyanidin antioxidants |
| 04/06/1999 | US5891901 Substituted pyrroles |
| 04/06/1999 | US5891900 Oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891872 Inhibit farnesyl-protein transferase |
| 04/06/1999 | US5891856 Nonmutating cells by treatment with metabolites and aminoalkylphosphorothioate |
| 04/06/1999 | US5891855 Contacting with cardiac glycoside |
| 04/06/1999 | US5891725 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891655 Screening low molecular weight compounds for modulation of fibroblast growth factor activity such as mitogenesis of receptor expressing cells as well as competitive binding with heparin to receptor and dimerization |
| 04/06/1999 | US5891468 Fusogenic liposome compositions and method |
| 04/06/1999 | US5891432 Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| 04/06/1999 | CA2152794C Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA2077394C Substituted taxanes and pharmaceutical compositions containing them |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340483C Diagnosis of retinoblastoma |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015665A2 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | WO1999015661A1 Cell growth regulator |
| 04/01/1999 | WO1999015659A2 Human ubiquitin-conjugating enzymes |
| 04/01/1999 | WO1999015658A2 Human regulatory molecules |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015535A1 Binuclear complex |
| 04/01/1999 | WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1999015508A1 Vitronectin receptor antagonists |
| 04/01/1999 | WO1999015505A1 1,5-diphenylpyrazole derivatives |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015498A1 New npy antagonists |
| 04/01/1999 | WO1999015201A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 04/01/1999 | WO1999015185A1 Agent for modifying the proliferation, functional activity and death of natural and tumoral cells |
| 04/01/1999 | WO1999015178A1 Vitronectin receptor antagonist |
| 04/01/1999 | WO1999015170A1 Vitronectin receptor antagonist |
| 04/01/1999 | WO1999015167A2 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 04/01/1999 | WO1999015153A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 04/01/1999 | WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/01/1999 | WO1999003878A3 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 04/01/1999 | WO1999003826A3 Metalloproteinase inhibitors |
| 04/01/1999 | WO1999002552A3 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/01/1999 | WO1999001117A3 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 04/01/1999 | WO1998054313A3 Dna methyltransferase genomic sequences and antisense oligonucleotides |
| 04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 04/01/1999 | WO1998051321A9 Tissue factor for influencing blood vessel formation |
| 04/01/1999 | WO1998051294A3 Method and composition for treating cancers |
| 04/01/1999 | WO1998043678B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
| 04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
| 04/01/1999 | CA2304599A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 04/01/1999 | CA2304485A1 Human regulatory molecules |
| 04/01/1999 | CA2304202A1 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2304126A1 Cell growth regulator |
| 04/01/1999 | CA2304000A1 Vitronectin receptor antagonist |
| 04/01/1999 | CA2303846A1 Vitronectin receptor antagonist |